Comparative Study of Pharmacokinetics and Renal Exposure of Salvianolic Acid B and Its Metabolite Danshensu in Normal and Renal Fibrosis Mice
- 26 April 2025
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (6) , e70094
Abstract
Salvianolic acid B (SAB), a water‐soluble compound in Salvia miltiorrhiza (Danshen), has been widely used in the treatment of renal fibrosis. This study aimed to investigate the pharmacokinetics of SAB and its active metabolite danshensu (DSS) after intraperitoneal injection of Salvia miltiorrhiza depside salt for injection (SDSI) or SAB in normal and unilateral ureteric obstruction (UUO) mice. An LC‐MS/MS method was developed to simultaneously determine the SAB and DSS in biological samples. The validation results showed that the linearity, accuracy and precision, matrix effects and recovery, and stability satisfied the FDA bioanalysis guidelines. Pharmacokinetic study showed that plasma and renal exposure of SAB in mice administered SAB were higher than that in mice administered SDSI in the sham group, while those of DSS were lower. Compared with the sham group, the AUC0‐t of SAB in obstructed kidneys (OKs) and non‐obstructed kidneys (NOKs) of the UUO group decreased by 71.14% and 54.63%, respectively. The AUC0‐t of DSS in the OKs and NOKs of the UUO group increased by 60.8% and 177.79%, respectively, compared with the sham group. Developed method was successfully applied to the bioanalysis of SAB and DSS. Our study provides pharmacokinetic support for the rational clinical application of SAB.Keywords
This publication has 22 references indexed in Scilit:
- Selective endothelin A receptor antagonism in chronic kidney disease: improving clinical applicationNephrology Dialysis Transplantation, 2025
- Salvianolic acid B attenuates tubulointerstitial fibrosis by inhibiting EZH2 to regulate the PTEN/Akt pathwayPharmaceutical Biology, 2022
- Danshen injection induces autophagy in podocytes to alleviate nephrotic syndrome via the PI3K/AKT/mTOR pathwayPhytomedicine, 2022
- Extra virgin olive oil-based phospholipid complex/self-microemulsion enhances oral absorption of salvianolic acid B through inhibition of catechol-O-methyltransferase-mediated metabolismInternational Journal of Pharmaceutics, 2022
- Principles of Kidney Pharmacotherapy for the Nephrologist: Core Curriculum 2021American Journal of Kidney Diseases, 2021
- Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular dockingBioscience Reports, 2021
- Salvianolic acid B attenuates epithelial-mesenchymal transition in renal fibrosis rats through activating Sirt1-mediated autophagyBiomedicine & Pharmacotherapy, 2020
- Renal Tubular Secretion of Tanshinol: Molecular Mechanisms, Impact on Its Systemic Exposure, and Propensity for Dose-Related Nephrotoxicity and for Renal Herb-Drug InteractionsDrug Metabolism and Disposition, 2015
- Methylation and its role in the disposition of tanshinol, a cardiovascular carboxylic catechol from Salvia miltiorrhiza roots (Danshen)Acta Pharmacologica Sinica, 2015
- The suffocating kidney: tubulointerstitial hypoxia in end-stage renal diseaseNature Reviews Nephrology, 2010